VEGFA and adrenal cortex carcinoma: Bedrose et al described the combination of lenvatinib (a multikinase VEGF inhibitor) with pembrolizumab in a small retrospective case series as salvage therapy in advanced ACC in heavily pretreated patients.63 The combination was reported to be well tolerated with no severe toxicities.